Anika Therapeutics, Inc is a biotechnology business based in the US. Anika Therapeutics shares (ANIK) are listed on the NASDAQ and all prices are listed in US Dollars. Anika Therapeutics employs 277 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Anika Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ANIK – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Anika Therapeutics stock price (NASDAQ: ANIK)Use our graph to track the performance of ANIK stocks over time.
Anika Therapeutics shares at a glance
|Latest market close||$46.65|
|52-week range||$32.04 - $48.37|
|50-day moving average||$43.16|
|200-day moving average||$40.49|
|Wall St. target price||$51.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.79|
Buy Anika Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Anika Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Anika Therapeutics price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||4.41%|
|3 months (2021-04-28)||14.28%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Is Anika Therapeutics under- or over-valued?
Valuing Anika Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Anika Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Anika Therapeutics's PEG ratio
Anika Therapeutics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 10.17. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Anika Therapeutics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Anika Therapeutics's EBITDA
Anika Therapeutics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $9.1 million.
The EBITDA is a measure of a Anika Therapeutics's overall financial performance and is widely used to measure a its profitability.
Anika Therapeutics financials
|Revenue TTM||$129.4 million|
|Gross profit TTM||$80.1 million|
|Return on assets TTM||-0.84%|
|Return on equity TTM||-9.45%|
|Market capitalisation||$575.5 million|
TTM: trailing 12 months
Shorting Anika Therapeutics shares
There are currently 1.4 million Anika Therapeutics shares held short by investors – that's known as Anika Therapeutics's "short interest". This figure is 8.4% down from 1.5 million last month.
There are a few different ways that this level of interest in shorting Anika Therapeutics shares can be evaluated.
Anika Therapeutics's "short interest ratio" (SIR)
Anika Therapeutics's "short interest ratio" (SIR) is the quantity of Anika Therapeutics shares currently shorted divided by the average quantity of Anika Therapeutics shares traded daily (recently around 130808.80077369). Anika Therapeutics's SIR currently stands at 10.34. In other words for every 100,000 Anika Therapeutics shares traded daily on the market, roughly 10340 shares are currently held short.
However Anika Therapeutics's short interest can also be evaluated against the total number of Anika Therapeutics shares, or, against the total number of tradable Anika Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Anika Therapeutics's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Anika Therapeutics shares in existence, roughly 90 shares are currently held short) or 0.1002% of the tradable shares (for every 100,000 tradable Anika Therapeutics shares, roughly 100 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Anika Therapeutics.
Find out more about how you can short Anika Therapeutics stock.
Anika Therapeutics share dividends
We're not expecting Anika Therapeutics to pay a dividend over the next 12 months.
Anika Therapeutics share price volatility
Over the last 12 months, Anika Therapeutics's shares have ranged in value from as little as $32.04 up to $48.37. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Anika Therapeutics's is 1.2247. This would suggest that Anika Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Anika Therapeutics overview
Anika Therapeutics, Inc. , together with its subsidiaries, operates as a joint preservation company that in the United States, Europe, and internationally. The company's joint pain management products include Monovisc and Orthovisc, which are single- and multi-injection, hyaluronic acid (HA)-based viscosupplements to provide pain relief from osteoarthritis (OA) conditions; Cingal, a novel, third-generation, single-injection OA product consisting of its proprietary cross-linked HA material combined with a steroid to provide short- and long-term pain relief; and Hyvisc, an injectable HA veterinary product for the treatment of joint dysfunction in horses. It also offers joint preservation and restoration products comprising preserving joint technologies, such as partial joint replacement, joint resurfacing, and minimally invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions caused by trauma, injury, and arthritic disease; soft tissue repair solutions used by surgeons to repair and reconstruct damaged ligaments and tendons resulting from sports injuries, trauma, and disease; Tactoset, an HA-enhanced injectable bone repair therapy to treat insufficiency fractures; and Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery. In addition, the company provides Hyalobarrier, an anti-adhesion barrier for use after abdomino-pelvic surgeries; Hyalomatrix for the treatment of complex wounds, such as burns and ulcers; products for the treatment of ears, nose, and throat disorder; and ophthalmic products, including injectables, high molecular weight HA products used as viscoelastic agents in ophthalmic surgical procedures, consisting of cataract extraction and intraocular lens implantation. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Stocks similar to Anika Therapeutics
Anika Therapeutics in the news
Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
Anika to Issue Second Quarter 2021 Financial Results on Thursday, August 5, 2021
Fly Intel: Top five analyst initiations
Frequently asked questionsWhat percentage of Anika Therapeutics is owned by insiders or institutions?
Currently 0.809% of Anika Therapeutics shares are held by insiders and 96.065% by institutions. How many people work for Anika Therapeutics?
Latest data suggests 277 work at Anika Therapeutics. When does the fiscal year end for Anika Therapeutics?
Anika Therapeutics's fiscal year ends in December. Where is Anika Therapeutics based?
Anika Therapeutics's address is: 32 Wiggins Avenue, Bedford, MA, United States, 01730 What is Anika Therapeutics's ISIN number?
Anika Therapeutics's international securities identification number is: US0352551081 What is Anika Therapeutics's CUSIP number?
Anika Therapeutics's Committee on Uniform Securities Identification Procedures number is: 035255108
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert